Glucocorticoid-induced hyperglycaemia in hospitalised adults: A matched cohort study (2013-2023).
Golubic R. et al, (2025), Diabetes Obes Metab
Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis.
Maddaloni E. et al, (2025), Diabetes Res Clin Pract
The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply.
Adler AI. et al, (2025), Lancet, 405
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92).
Lin B. et al, (2024), Lancet Diabetes Endocrinol
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
Juraschek SP. et al, (2023), JAMA, 330, 1459 - 1471
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Hundertmark MJ. et al, (2023), Circulation, 147, 1654 - 1669
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.
Othonos N. et al, (2023), Nat Commun, 14
Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
Xu S. et al, (2022), Cardiovasc Diabetol, 21
Effect of Fenofibrate Therapy on Laser Treatment for Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials.
Preiss D. et al, (2022), Diabetes Care, 45, e1 - e2
The effect of fenofibrate therapy on laser treatment for diabetic retinopathy: a meta-analysis of randomized trials
Preiss D. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance.
Xu S. et al, (2021), J Diabetes, 13, 817 - 826
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure.
Hundertmark MJ. et al, (2021), ESC Heart Fail, 8, 2580 - 2590
Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89.
Wamil M. et al, (2021), Diabetes Care, 44, 1877 - 1884
Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88.
Lind M. et al, (2021), Diabetes Care
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis.
Juraschek SP. et al, (2021), Ann Intern Med, 174, 58 - 68